Volume 3, Issue 3 (September 2017)                   mazums-pbr 2017, 3(3): 1-11 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alinezhad V, Alinezhad H, Ataee R, Ataie A. Utilization of curcumine and nanocurcumine compounds in cancer therapy. mazums-pbr. 2017; 3 (3) :1-11
URL: http://pbr.mazums.ac.ir/article-1-178-en.html
Bsc Faculty of chemistry, University of Mazandaran, Babolsar, Iran
Abstract:   (565 Views)
Curcumin is a polyphenol extracted from the Curcuma plant. Curcumin has been used widely in ayurvedic medicine for centuries; it has a variety of biological properties including anti-oxidant, analgesic, anti-inflammatory and antiseptic activity. Curcumin has shown anti-cancer activities through variety of biological pathways engaged in mutagenesis, oncogene expression, cell cycle regulation, apoptosis, tumorigenesis and metastasis. Curcumin has proved anti-proliferative effect in many cancers, and is an inhibitor of the transcription factor NF-κB and downstream gene products (including c-myc, Bcl-2, COX-2, NOS, Cyclin D1, TNF-α, interleukins and MMP-9). Furthermore, curcumin affects a variety of growth factor receptors and cell adhesion molecules involved in tumor growth, angiogenesis and metastasis. However, a limiting factor is its extremely low bioavailability which hinders its use as therapeutic agent. Therefore, many technologies have been developed to overcome this limitation. We summarize to develop curcumin delivery aims and increase solubility for improving curcumin bioavailability and anticancer potential for therapy.
 
Full-Text [PDF 1174 kb]   (247 Downloads)    
Type of Study: Review | Subject: Nanotechnology

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2018 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb